Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
5.46
-0.06 (-1.09%)
At close: Aug 29, 2025, 4:00 PM
5.40
-0.06 (-1.10%)
After-hours: Aug 29, 2025, 6:51 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $374.74 million as of August 29, 2025. Its market cap has decreased by -47.74% in one year.
Market Cap
374.74M
Enterprise Value
17.59M
1-Year Change
-47.74%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $374.74M, a decrease of -79.12%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 378.86M | -11.90% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
| Nov 19, 2020 | 1.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |